Skip to content
The Policy VaultThe Policy Vault

oral chemotherapeutic agentsUnited Healthcare

non-oncology indications recognized in product labeling, a published compendium (e.g., Micromedex, Clinical Pharmacology), or demonstrated as proven in peer reviewed medical literature

Initial criteria

  • Patient is under the age of 19 years OR
  • Drug is recognized for treatment of the cancer indication by the NCCN Drugs and Biologics Compendium with a Category of Evidence and Consensus of 1, 2A, or 2B OR
  • Patient is receiving treatment for a non-oncology indication that is recognized in the product labeling, a published compendium (e.g., Micromedex, Clinical Pharmacology), or is demonstrated as proven in the peer reviewed medical literature

Approval duration

12 months